Thomas Weimbs

14PUBLICATIONS
19CO-AUTHORS
Nutrigenomics and personalised nutritionClinical nutritionMolecular targetsFood properties (incl. characteristics and health benefits)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 30, 2026
β-Hydroxybutyrate: a renoprotective hormone in polycystic kidney disease.

|Oct 16, 2024
Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.

Melina Messing, Jacob A Torres, Nickolas Holznecht

|Jan 08, 2024
Ketogenic metabolic therapy for chronic kidney disease - the pro part.

Thomas Weimbs, Jessianna Saville, Kamyar Kalantar-Zadeh

|Dec 14, 2023
A combination of β-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease.

Jacob A Torres, Nickolas Holznecht, David A Asplund

|Nov 24, 2022
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.

Simon Oehm, Konstantin Steinke, Johannes Schmidt

|Jul 22, 2022
Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression.

Masaw Akbari, Jonathan D West, Nicholas Doerr

Pageof 3

Frequent Collaborators

4 joint publications

Jacob A Torres

1 joint publications

Laurent Meijer

1 joint publications

Masaw Akbari

1 joint publications

Nicholas Doerr